Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP397260.RApVJ8n4LJEpdMjX8y858oCbo-rk1ZFZUZzEky0gPJoqw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP397260.RApVJ8n4LJEpdMjX8y858oCbo-rk1ZFZUZzEky0gPJoqw130_assertion type Assertion NP397260.RApVJ8n4LJEpdMjX8y858oCbo-rk1ZFZUZzEky0gPJoqw130_head.
- NP397260.RApVJ8n4LJEpdMjX8y858oCbo-rk1ZFZUZzEky0gPJoqw130_assertion description "[These data indicate that quantity and lytic efficiency of CD16(+) lymphocytes are major factors for ADCC induction by trastuzumab, and confirm that breast cancer responses to short-term trastuzumab monotherapy may depend on involvement of the ADCC mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP397260.RApVJ8n4LJEpdMjX8y858oCbo-rk1ZFZUZzEky0gPJoqw130_provenance.
- NP397260.RApVJ8n4LJEpdMjX8y858oCbo-rk1ZFZUZzEky0gPJoqw130_assertion evidence source_evidence_literature NP397260.RApVJ8n4LJEpdMjX8y858oCbo-rk1ZFZUZzEky0gPJoqw130_provenance.
- NP397260.RApVJ8n4LJEpdMjX8y858oCbo-rk1ZFZUZzEky0gPJoqw130_assertion SIO_000772 18089830 NP397260.RApVJ8n4LJEpdMjX8y858oCbo-rk1ZFZUZzEky0gPJoqw130_provenance.
- NP397260.RApVJ8n4LJEpdMjX8y858oCbo-rk1ZFZUZzEky0gPJoqw130_assertion wasDerivedFrom befree-20150227 NP397260.RApVJ8n4LJEpdMjX8y858oCbo-rk1ZFZUZzEky0gPJoqw130_provenance.
- NP397260.RApVJ8n4LJEpdMjX8y858oCbo-rk1ZFZUZzEky0gPJoqw130_assertion wasGeneratedBy ECO_0000203 NP397260.RApVJ8n4LJEpdMjX8y858oCbo-rk1ZFZUZzEky0gPJoqw130_provenance.